Skip to main content
Clinical Trials/NCT02241863
NCT02241863CompletedNot Applicable

The Effect of a Theory Based Educational Intervention on Medication Adherence to and Removes of Related Barriers in Patients With Bipolar Disorder

Qazvin University Of Medical Sciences10 sites in 1 country270 target enrollmentStarted: September 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
270
Locations
10
Primary Endpoint
changes in Patient-reported medication Adherence to mood stabilizers

Study Overview

Brief Summary

Despite an increasing pharmacopoeia of effective medications for the treatment of bipolar disorder, patient outcomes continue to be impacted by treatment adherence. Non-adherence to treatments is also a major obstacle in translating efficacy in research settings into effectiveness in clinical practice. Non-adherence with bipolar disorder (BD) medication treatment dramatically worsens outcomes. Reasons for non-adherence among individuals with BD are multi-dimensional, and it has been suggested that a multifaceted intervention will be more effective. The study is aimed to assess the effectiveness of a multifaceted intervention on enhancing medications adherence in patients with bipolar disorders.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age ≥18 years
  • •meeting DSM-IV criteria for bipolar I or II disorder
  • •concurrently treated with a mood stabilizer
  • •not currently in weekly or biweekly psychotherapy
  • •Persian speaking.

Exclusion Criteria

  • •DSM-IV drug or alcohol misuse disorders (excluding nicotine),
  • •pregnancy or planning pregnancy in the next year
  • •requiring changing the drug or the dose of a mood stabilizer
  • •evidence of severe DSM-IV borderline personality
  • •Unable or unwilling to give written informed consent.
  • •An organic cerebral cause for bipolar disorder-for example, multiple sclerosis or stroke.
  • •intellectual disability

Arms & Interventions

Multifaceted intervention

Experimental

Patients, their caregivers and family members will received the educational and motivational interventions

Intervention: Multifaceted intervention (Behavioral)

Active Comparator

Active Comparator

Usual Care The usual care group received routine counseling performed by the psychiatrist and nurses.

Intervention: Routine counseling (Behavioral)

Outcomes

Primary Outcomes

changes in Patient-reported medication Adherence to mood stabilizers

Time Frame: changes from baseline, 1 Months and 6 months follow-up

The Medication Adherence Report Scale (MARS-5) will be used for assessing medication adherence to the mood stabilizers

Secondary Outcomes

  • Changes in Montgomery Asberg Depression Rating Scale(Changes from baseline, 1 Months and 6 months after the intervention)
  • Plasma level of mood stabilizer(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in coping planning(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in Young Mania Rating Scale (YMRS)(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in action planning(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in quality of life(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in psychological predictors of medication adherence (intention, perceived behavioral control ,Self-monitoring and Behaviour Automaticity)(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in Global Impression for Bipolar Disorder Severity scale (CGI-BP-S)(Changes from baseline, 1 Months and 6 months after the intervention)
  • Changes in Beliefs about Medicines Questionnaire (BMQ)(Changes from baseline, 1 Months and 6 months after the intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amir H Pakpour

Head of the Social Determinants of Health Research Center

Qazvin University Of Medical Sciences

Study Sites (10)

Loading locations...

Similar Trials